Breaking Down Nanjing Gaoke Company Limited Financial Health: Key Insights for Investors

Nanjing Gaoke Company Limited's recent financials demand a closer look: revenue plunged to 1.98 billion CNY in 2024, down 58.16% from 4.73 billion CNY after a real estate slump that saw contracted sales area fall 92.66% and contracted sales amount drop 67.59%, yet the company still reported a 1.73 billion CNY net income in 2024 (up 10.58%) and an eye-catching 87.4% net profit margin; early signs of recovery appear with Q1 2025 revenue at 1.06 billion CNY (a 274.9% year-on-year jump) driven by real estate sales and investment income, while key balance-sheet figures show total assets of 40.32 billion CNY, total debt of 10.75 billion CNY (debt-to-equity 51.5%) and cash of 2.69 billion CNY leaving a cash-to-debt ratio near 25% amid a negative operating cash flow of -68.13 million CNY; valuation metrics add to the intrigue with a trailing P/E of 6.18, P/B of 0.70 and market cap around 15.09 billion CNY, all set against growth levers in venture investments and recovering real estate sales-read on for the detailed breakdown investors need.

Nanjing Gaoke Company Limited (600064.SS) - Revenue Analysis

• 2024 revenue: 1.98 billion CNY (-58.16% YoY)
• 2023 revenue: 4.73 billion CNY
• Contracted sales area change (2024 vs 2023): -92.66%
• Contracted sales amount change (2024 vs 2023): -67.59%
• Q1 2025 revenue: 1.06 billion CNY (+274.9% YoY)
• Revenue per employee: 4.47 million CNY (648 employees)
• Market capitalization: ~15.09 billion CNY

Nanjing Gaoke Company Limited (600064.SS) - Profitability Metrics

Nanjing Gaoke reported strong bottom-line performance in 2024 despite revenue pressure, driven by cost control and high-margin items. Key profitability figures for investors to note:

• Net income (2024): 1.73 billion CNY, up 10.58% year-over-year.
• Net profit margin (2024): ~87.4%.
• Operating margin (TTM): 9.36%.
• Return on equity (TTM): 9.17%.
• Earnings per share (TTM): 1.34 CNY; P/E ratio: 6.18.
• Dividend yield: 3.61%; payout ratio: 25.62%.

• Valuation context: P/E 6.18 with EPS 1.34 CNY points to a low multiple relative to earnings - warrants comparative peer analysis.
• Profit structure: very high net profit margin alongside a moderate operating margin suggests significant non-operating gains or one-off items impacting net income; investigate income statement details.
• Shareholder returns: 3.61% yield and a 25.62% payout ratio balance cash returns with reinvestment capacity.

For additional corporate context, see Mission Statement, Vision, & Core Values (2026) of Nanjing Gaoke Company Limited.

Nanjing Gaoke Company Limited (600064.SS) - Debt vs. Equity Structure

Key balance-sheet metrics and financing characteristics for Nanjing Gaoke Company Limited (600064.SS) highlight a capital structure with meaningful leverage but also a solid asset base and improving financing costs.

• Total debt: 10.75 billion CNY
• Total assets: 40.32 billion CNY
• Total liabilities: 19.44 billion CNY
• Total cash holdings: 2.69 billion CNY
• Book value per share: 11.15 CNY
• Average cost of financing (2024): 2.72% (down 0.27 ppt YoY)

Implications for investors:

• The company carries moderate leverage: debt-to-equity at 51.5% and debt-to-assets ~48.2%.
• Cash cushions cover roughly a quarter of total debt, suggesting limited immediate liquidity to retire obligations outright.
• Absence of an interest coverage ratio constrains assessment of near-term solvency and interest-service ability.
• Book value per share (11.15 CNY) exceeding market price can signal potential undervaluation, subject to quality of underlying assets and off-balance risks.
• Declining financing costs (2.72% in 2024) reduce interest burden and support debt servicing if sustained.

For broader context on the company's strategic positioning and corporate priorities, see: Mission Statement, Vision, & Core Values (2026) of Nanjing Gaoke Company Limited.

Nanjing Gaoke Company Limited (600064.SS) - Liquidity and Solvency

Nanjing Gaoke's short-term liquidity and longer-term solvency present a mixed picture: the company shows adequate near-term coverage by current assets but faces cash-generation weakness and a sizeable debt load relative to available cash and total assets.

• Current ratio: 1.23 - sufficient short-term assets to cover short-term liabilities, but not by a large margin.
• Quick ratio: not specified; however, the current ratio suggests adequate but limited liquidity.
• Operating cash flow (TTM): -68.13 million CNY - negative operating cash flow signals challenges in converting revenue into cash from core operations.
• Cash position: 2.69 billion CNY versus total debt: 10.75 billion CNY - cash covers only ~25.0% of total debt, indicating potential solvency pressure if debt-rollover or liquidity needs arise.
• Total liabilities: 19.44 billion CNY; total assets: 40.32 billion CNY - debt-to-assets ≈ 48.2%, reflecting a moderately leveraged balance sheet.
• Average cost of financing (2024): 2.72%, down 0.27 percentage points year-over-year - financing costs are declining, easing interest burden.

• Key risk points: negative operating cash flow, cash covering ~25% of total debt, total liabilities near half of asset base.
• Key mitigant: declining average financing cost (2.72% in 2024) reduces interest burden and may improve debt servicing capacity if sustained.
• Monitor: improvements in operating cash flow, changes to quick ratio (inventory and receivables composition), debt maturities and refinancing terms.

Further context and investor positioning can be found here: Exploring Nanjing Gaoke Company Limited Investor Profile: Who's Buying and Why?

Nanjing Gaoke Company Limited (600064.SS) - Valuation Analysis

Key market valuation metrics for Nanjing Gaoke Company Limited (600064.SS) reveal mixed signals: low P/E multiples and a P/B below 1 point to potential undervaluation, while a negative EV/EBITDA and an intrinsic value below the current price raise caution about operational performance and possible overvaluation at current market levels. Relevant metrics are summarized below.

• Low trailing and forward P/E (6.18 / 5.65): indicates the market is pricing earnings conservatively but also suggests relative cheapness versus many industry peers.
• P/B of 0.70: equity market value below book value - could reflect real asset undervaluation or concerns about asset quality and future returns.
• P/S of 5.21 and EV/Revenue of 8.00: investors assign a high revenue multiple relative to sales, implying revenue is valued but margins/earnings may be uncertain.
• Negative EV/EBITDA (-48.10): driven by negative EBITDA - a red flag for operating profitability and cash-generation issues; makes typical EV/EBITDA comparisons unreliable.
• Intrinsic value 5.47 CNY vs market 8.06 CNY: model implies the stock is ~32.19% over intrinsic value, warranting scrutiny of the assumptions behind the intrinsic estimate and of market expectations.

For strategic context, see Mission Statement, Vision, & Core Values (2026) of Nanjing Gaoke Company Limited.

Nanjing Gaoke Company Limited (600064.SS) - Risk Factors

Nanjing Gaoke faces several material risks that can affect its liquidity, earnings sustainability, and strategic trajectory. Below are the principal risk drivers investors should evaluate alongside available quantitative signals.

• Leverage pressure: debt-to-equity ratio 51.5%, which limits financial flexibility and increases interest burden sensitivity to rate moves.
• Operating cash flow strain: negative operating cash flow of -68.13 million CNY, indicating core operations are not currently generating cash to fund working capital or service debt.
• Core demand decline: a documented fall in real estate sales and related revenue, pressuring margins and backlog monetization for the company's traditional property business.
• Investment exposure: sizable allocations to venture capital and non-core sectors that introduce market volatility and potential mark-to-market losses.
• Government dependence: substantial reliance on municipal contracts and government relationships, making revenue and project pipelines vulnerable to policy or procurement shifts.
• Expansion and integration risk: moves into new business areas entail execution challenges, management bandwidth constraints, and additional operational risk.

• Short-term liquidity and refinancing risk: with negative operating cash flow and material debt, the company may need to refinance, sell assets, or secure additional capital on potentially unfavorable terms.
• Profitability volatility: continued weak property sales plus mark-to-market losses on investments can depress margins and EPS, increasing the probability of earnings misses.
• Concentration risk: reliance on municipal contracts concentrates counterparty and policy risk; any slowdown or re-prioritization by local governments could reduce awarded projects.
• Execution risk for diversification: moving into tech, VC, or other sectors requires new capabilities; failures or delays could generate impairments or higher operating costs.
• Interest rate and macro sensitivity: higher rates increase debt servicing costs and can further cool property demand, compounding cash flow pressure.

Investors should monitor quarterly operating cash flow trends, leverage movements, asset disposals or capital raises, realized/unrealized investment losses, and the company's disclosure on municipal contract exposure and contingency plans. For strategic context and stated corporate priorities, see: Mission Statement, Vision, & Core Values (2026) of Nanjing Gaoke Company Limited.

Nanjing Gaoke Company Limited (600064.SS) - Growth Opportunities

• Venture capital and strategic equity: The company's VC portfolio, including a meaningful stake in Chenpai Pharmaceutical, provides upside via potential IPOs, M&A or royalty streams. Management disclosed participation in rounds totaling approximately RMB 220-280 million across life sciences and advanced manufacturing between 2023-2025.
• Real estate recovery signals: Contracted sales area and contracted sales amount rose year-on-year in early 2025 - contracted GFA increased ~18% while contracted sales value improved ~24%, indicating improving market absorption in key Nanjing and Jiangsu micro-markets.
• Expansion into high-growth verticals: New business lines - pharmaceutical production, healthcare consulting, and tailored financial services for technology startups - offer diversification away from cyclical property sales toward higher-margin service and recurring-revenue models.
• Strategic partnerships and long-term contracts: Cooperation agreements with municipal governments and multinational enterprises (including long-term facility management and urban renewal contracts) create predictable revenue corridors and reduced project execution risk.
• Municipal & infrastructure alignment: Focus on municipal works (transport, water, public facilities) aligns Gaoke with national urbanization and new-type urbanization projects; backlog of municipal contracts at end-2024 exceeded RMB 1.1 billion, offering visible revenue conversion in 2025-2027.
• Business transformation: Ongoing restructuring of on-balance-sheet assets, joint ventures, and asset-light service platforms is expected to lower real estate leverage and open new fee-based revenue streams over 24-36 months.

• Exit catalysts for VC holdings - valuation inflection from Chenpai Pharmaceutical milestones (clinical, regulatory or strategic sale) could materially uplift asset value.
• Conversion rate from contracted sales to recognized revenue; a >80% conversion within 12 months supports near-term cash flows and deleveraging.
• Margin mix shift as service and healthcare segments scale - target operating margin improvement of 3-6 percentage points if management achieves scale and cross-selling.
• Project financing and partnership structures for municipal projects - non-recourse or PPP arrangements reduce balance-sheet strain and accelerate ROE.